SCHEMBL3208846

SCHEMBL3208846

Cn1cccc1C(=O)NCCc1ccc(O)c(Br)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.64
NPC1 O15118 2/20 0.64
HRH3 Q9Y5N1 5/20 0.64
HDAC6 Q9UBN7 3/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
PLK4 O00444 1/20 0.45
AURKA O14965 1/20 0.45
NUAK1 O60285 1/20 0.45
EGFR P00533 1/20 0.45
ERBB2 P04626 1/20 0.45
INSR P06213 1/20 0.45
IGF1R P08069 1/20 0.45
MET P08581 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3200565 0.85 HRH3 (0.73) RAB9ANPC1HRH3HDAC6HDAC1
SCHEMBL3768440 0.79 NPC1 (1.00) RAB9ANPC1HRH3HDAC6HDAC1
SCHEMBL3198458 0.79 HRH3 (1.00) RAB9ANPC1HRH3
SCHEMBL3208449 0.78 HRH3 (1.00) RAB9ANPC1HRH3
SCHEMBL30983754 0.76 KDM4E (0.73) HDAC6HDAC1PLK4AURKANUAK1
SCHEMBL29210589 0.76 KDM4E (0.73) HDAC6HDAC1PLK4AURKANUAK1
SCHEMBL27944339 0.74 PLK4 (0.55) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL22222495 0.74 NPC1 (0.70) RAB9ANPC1HRH3LMNAMAPT
SCHEMBL3191975 0.74 HRH3 (1.00) RAB9ANPC1HRH3KMT2A
SCHEMBL3206922 0.73 HRH3 (0.61) HRH3HDAC6HDAC1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 US disclosed
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 US disclosed
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 US disclosed
WO-2009152071-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY (US) 2009-12-17 WO disclosed
WO-2009152071-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF HRH3, HRH4, HRH1 RAB9A 2270/4885NPC1 462/4885HRH3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.